Wednesday, June 22, 2016

Graham analysis Corbion (previously CSM) AEX CRBN NL0010583399

Note: I don't understand this company, the history or the numbers. I am clueless.

SECTOR: [FAIL]  Corbion is a bio-technology company? and therefore Benjamin Graham would consider it too risky. 

SALES: [PASS] The investor must select companies of "adequate size". This includes companies with annual sales greater than €260 million. Corbion's sales of €918 million, based on 2015 sales, passes this test.

CURRENT RATIO:  [PASS] The current ratio must be greater than or equal to 2. Companies that meet this criterion are typically financially secure and defensive. Corbion's current ratio €338m/€135m of 2.5 is good.

LONG-TERM DEBT IN RELATION TO NET CURRENT ASSETS: [PASS]  For industrial companies, long-term debt must not exceed net current assets (current assets minus current liabilities). Companies that do not meet this criterion lack the financial stability that this methodology likes to see. The long-term debt for Corbion is €166 million, while the net current assets are €203 million. Corbion passes this test.

LONG-TERM EPS GROWTH:  [FAIL] Companies must increase their EPS by at least 30% over a ten-year period and EPS must not have been negative for any year within the last 5 years. Companies with this type of growth tend to be financially secure and have proven themselves over time. Corbion's earnings have not increased much over the past ten years and it has made losses recently.

Earnings Yield: [FAIL] The Earnings/Price (inverse P/E) %, based on the lesser of the current Earnings Yield or the Yield using average earnings over the last 3 fiscal years, must be "acceptable", which this methodology states is greater than 6,5%. Stocks with higher earnings yields are more defensive by nature. Corbion's E/P of 6% (using this years estimated Earnings) fails this test.

Graham Number value: [FAIL]  The Price/Book ratio must also be reasonable. That is the Graham number value must be greater than the market price. Corbion has a Graham number of (15 x €1,1 EPS x 1,5 x €8,2 Book Value) = €14,3 

Dividend: €0,40/€21,5 = 2% ? Dividend 2016?  

Conclusion: I don't know enough about the company or business to say much. Earnings of €1,5 per share x 15 = €22,50 shows the price (€21,50 per share) is not ridiculously high or low at the moment?  

See: for more in depth, qualitative analysis of "good" companies.

My previous numbers had Corbion aka CSM making a profit in 2012?

Comments, questions or E-mails welcome:

No comments: